🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of the study will be to assess the efficacy and safety o...
Status
Completed
Location
Peking University First Hospital
Start Date
2023-06-28
Trial ID
NCT07704684
Treatments Being Tested
This study is to evaluate the bioequivalence of Valsatril (Sacubitril/Valsa...
Status
Completed
Location
Center for Bioequivalence Studies and Clinical Research (CBSCR) , ICCBS, University of Karachi
Start Date
2025-02-06
Trial ID
NCT07746908
Treatments Being Tested
An open label, balanced, randomized, single dose, two treatment, two sequen...
Status
Completed
Location
Veeda Clinical Research Ltd.
Start Date
2024-12-28
Trial ID
NCT06922253
Treatments Being Tested
The main objective of the study will be to assess the efficacy and safety o...
Status
Completed
Location
Peking University First Hospital
Start Date
2024-11-23
Trial ID
NCT07704697
The study is to compare the rate and extent of absorption of a generic form...
Status
Unknown
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06248112
Treatments Being Tested
Investigators are building an empirical evidence base for real world data t...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2020-09-22
Trial ID
NCT04736433
Treatments Being Tested
Primary objective is to is to evaluate the bioequivalence of two formulatio...
Status
Unknown
Location
Multiple Locations
Start Date
2024-03
Trial ID
NCT06266988
To evaluate the bioequivalence between two formulations of sacubitril/valsa...
Status
Unknown
Location
Siriraj Institute of Clinical Research (SICRES)
Start Date
2024-01
Trial ID
NCT06193187
Treatments Being Tested
Primary objective is to is to evaluate the bioequivalence of two formulatio...
Status
Unknown
Location
Medica Innova Co Ltd
Start Date
2024-04
Trial ID
NCT06273254